You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 14, 2024

Investigational Drug Information for Apaziquone

✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for Apaziquone?

Apaziquone is an investigational drug.

There have been 9 clinical trials for Apaziquone. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2007.

The most common disease conditions in clinical trials are Urinary Bladder Neoplasms and [disabled in preview]. The leading clinical trial sponsors are Spectrum Pharmaceuticals, Inc, Handok Inc., and Handok Pharmaceuticals Co., Ltd.

Recent Clinical Trials for Apaziquone
A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT)Spectrum Pharmaceuticals, IncPhase 3
A Study of Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT)Spectrum Pharmaceuticals, IncPhase 3
Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)AllerganPhase 3

See all Apaziquone clinical trials

Clinical Trial Summary for Apaziquone

Top disease conditions for Apaziquone
Top clinical trial sponsors for Apaziquone

See all Apaziquone clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.